Differences in Endothelial Activation and Dysfunction Induced by Antiphospholipid Antibodies Among Groups of Patients With Thrombotic, Refractory, and Non-refractory Antiphospholipid Syndrome
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by pregnancy morbidity or thrombosis and persistent antiphospholipid antibodies (aPL) that bind to the endothelium and induce endothelial activation, which is evidenced by the expression of adhesion molecules and the production...
Guardado en:
Autores principales: | Manuela Velásquez, Luisa F. Peláez, Mauricio Rojas, Raúl Narváez-Sánchez, Jesús A. Velásquez, Carlos Escudero, Sebastián San Martín, Ángela P. Cadavid |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6dda233c52a8468f88b3e54908534d06 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antiphospholipid Antibodies From Women With Pregnancy Morbidity and Vascular Thrombosis Induce Endothelial Mitochondrial Dysfunction, mTOR Activation, and Autophagy
por: Carlos M. Rodríguez, et al.
Publicado: (2021) -
Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome
por: Katrien M.J. Devreese, et al.
Publicado: (2021) -
Oxidative Stress in the Pathogenesis of Antiphospholipid Syndrome: Implications for the Atherothrombotic Process
por: Cristina Nocella, et al.
Publicado: (2021) -
Approaches to the realization of reproductive function in women with systemic lupus erythematosus and antiphospholipid syndrome
por: Galina A. Vlasova, et al.
Publicado: (2021) -
HLA DRB1 and HLA DQB1 Alleles in Bulgarian Patients with Primary and Secondary Antiphospholipid Syndrome
por: Baleva M., et al.
Publicado: (2019)